Literature DB >> 15189190

Pichia anomala fungaemia in immunocompromised children.

M Bakir1, N Cerikcioğlu, A Tirtir, S Berrak, E Ozek, C Canpolat.   

Abstract

Pichia anomala is an emerging yeast causing serious nosocomial infections in newborn and immunocompromised children. We describe nosocomial port catheter infection due to P. anomala in three children who were receiving cancer chemotherapy, bloodstream infection in a preterm infant and in an infant with severe combined immunodeficiency. All patients were treated with amphotericin B. All isolates were susceptible to amphotericin B and fluconazole. No recurrence was observed during follow-up in four of five patients. The common clinical feature in all of our patients was the presence of prior antimicrobial therapy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15189190     DOI: 10.1111/j.1439-0507.2004.00962.x

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


  9 in total

1.  Antifungal drug susceptibility profile of Pichia anomala isolates from patients presenting with nosocomial fungemia.

Authors:  Vânia Lúcia Ribeiro da Matta; Márcia de Souza Carvalho Melhem; Arnaldo Lopes Colombo; Maria Luiza Moretti; Laura Rodero; Gisele Madeira Duboc de Almeida; Marilena dos Anjos Martins; Silvia Figueiredo Costa; Maria Beatriz G Souza Dias; Márcio Nucci; Anna S Levin
Journal:  Antimicrob Agents Chemother       Date:  2007-01-29       Impact factor: 5.191

2.  Pichia farinosa bloodstream infection in a lymphoma patient.

Authors:  A Adler; C Hidalgo-Grass; T Boekhout; B Theelen; E Sionov; I Polacheck
Journal:  J Clin Microbiol       Date:  2007-08-15       Impact factor: 5.948

3.  Pichia anomala (Candida pelliculosa) fungemia in a patient with sickle cell disease.

Authors:  Austin W Chan; Emily J Cartwright; Sujan C Reddy; Colleen S Kraft; Yun F Wang
Journal:  Mycopathologia       Date:  2013-07-25       Impact factor: 2.574

4.  Complete mitochondrial genome sequence of the yeast Pichia farinosa and comparative analysis of closely related species.

Authors:  Paul P Jung; Anne Friedrich; Jean-Luc Souciet; Véronique Louis; Serge Potier; Jacky de Montigny; Joseph Schacherer
Journal:  Curr Genet       Date:  2010-09-10       Impact factor: 3.886

5.  Smokeless tobacco consumption induces dysbiosis of oral mycobiome: a pilot study.

Authors:  Mohammad Sajid; Pragya Sharma; Sonal Srivastava; Roopa Hariprasad; Harpreet Singh; Mausumi Bharadwaj
Journal:  Appl Microbiol Biotechnol       Date:  2022-08-01       Impact factor: 5.560

6.  In vitro activity of seven systemically active antifungal agents against a large global collection of rare Candida species as determined by CLSI broth microdilution methods.

Authors:  D J Diekema; S A Messer; L B Boyken; R J Hollis; J Kroeger; S Tendolkar; M A Pfaller
Journal:  J Clin Microbiol       Date:  2009-08-26       Impact factor: 5.948

Review 7.  Fungal infections in primary immunodeficiencies.

Authors:  Charalampos Antachopoulos; Thomas J Walsh; Emmanuel Roilides
Journal:  Eur J Pediatr       Date:  2007-06-06       Impact factor: 3.183

Review 8.  The Biology of Pichia membranifaciens Killer Toxins.

Authors:  Ignacio Belda; Javier Ruiz; Alejandro Alonso; Domingo Marquina; Antonio Santos
Journal:  Toxins (Basel)       Date:  2017-03-23       Impact factor: 4.546

9.  Composition and Ecological Functionality of Fungal Communities Associated with Smokeless Tobacco Products Mainly Consumed in India.

Authors:  Mohammad Sajid; Sonal Srivastava; Ravi Kumar Yadav; Harpreet Singh; Shalini Singh; Mausumi Bharadwaj
Journal:  Microbiol Spectr       Date:  2022-06-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.